MORRISTOWN MEDICAL CENTER
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $40.8M
- Transactions
- 5,583
- Companies
- 40
- Average per transaction
- $7,301
Who reported the payments
| Edwards Lifesciences | $16,159,322 |
| Merck | $3,124,194 |
| E.r. Squibb & Sons, L.L.C. | $2,085,995 |
| Beigene, Ltd. | $1,957,722 |
| Imclone Systems, LLC | $1,785,549 |
| Bristol Myers Squibb | $1,547,343 |
| Medtronic | $1,332,942 |
| Vertex | $1,164,547 |
| Novartis | $996,540 |
| AstraZeneca | $917,710 |
| AbbVie | $616,893 |
| Eli Lilly | $535,639 |
| Roche Products Limited | $426,540 |
| Sanofi US Services Inc. | $419,398 |
| Takeda Pharmaceuticals U.S.A., Inc. | $373,949 |
| Jazz Pharmaceuticals Inc. | $372,287 |
| Regeneron | $366,717 |
| Abbott | $327,287 |
| Pfizer | $307,373 |
| Urogen Pharma, Inc. | $302,330 |
| Amgen | $299,895 |
| Biomarin Pharmaceutical Inc. | $264,172 |
| Genentech, Inc. | $231,622 |
| Tesaro, Inc. | $230,443 |
| Beone Medicines Ltd. | $224,574 |
| Sanofi Pasteur Inc. | $207,690 |
| Janssen Research & Development, LLC | $197,292 |
| Cardiva Medical, Inc. | $188,340 |
| Acutus Medical, Inc. | $170,500 |
| Alkermes, Inc. | $169,676 |
| Novo Nordisk AS | $161,037 |
| Aadi Bioscience, Inc. | $149,911 |
| Biontech SE | $130,668 |
| Stryker | $125,610 |
| Seagen Inc. | $117,840 |
| Array Biopharma Inc | $113,257 |
| GE HealthCare | $107,664 |
| Balt USA, LLC | $106,644 |
| Exelixis Inc. | $106,122 |
| Incyte Corporation | $100,090 |